© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Valeant Acquisition of Salix Pharmaceuticals
Posted 27th February 2015

Valeant Acquisition of Salix Pharmaceuticals

NULL

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Valeant Acquisition of Salix Pharmaceuticals
Image

Valeant Acquisition of Salix Pharmaceuticals

Valeant Pharmaceuticals International, Inc. and Salix Pharmaceuticals, Ltd. announced that they have entered into a definitive agreement under which Valeant will acquire all of the outstanding common stock of Salix for $158.00 per share in cash, or a total enterprise value of approximately $14.5 billion. The transaction was approved by the Boards of Directors of both companies. 

Salix Pharmaceuticals is a widely recognized gastrointestinal market leader with a portfolio of 22 total products, including well-known prescription brands Xifaxan, Uceris, Relistor, and Apriso, as well as a strong near- term pipeline of innovative, new assets. 

“Salix’s market-leading gastrointestinal franchise is an ideal strategic fit for Valeant’s diversified portfolio of specialty products,” said J. Michael Pearson, Valeant’s chairman and chief executive officer. “The growing GI market has attractive fundamentals, and Salix has a portfolio of terrific products that are outpacing the market in terms of volume growth and a promising near-term pipeline of innovative products. With strong brand recognition among specialist GI prescribers, a highly rated specialty sales force, and a significant product and commercial presence across the undertreated and underserved gastrointestinal market, this acquisition offers a compelling opportunity for Valeant to create a strong platform for growth and business development.” 

Thomas W. D’Alonzo, Chairman of the Board and Acting Chief Executive Officer of Salix, stated, “We are pleased to have reached an agreement with Valeant, which is a logical partner and importantly, creates immediate value for our shareholders. Combining Salix’s leading market position in gastroenterology with Valeant’s scale and resources will create a stronger and more diverse business committed to providing better health solutions to health care providers and their patients. We are proud of the accomplishments of our Salix team. Together, we have built our company into the leading gastrointestinal specialty pharmaceutical company, providing solutions for patients and healthcare providers. We look forward to working with the Valeant team to ensure a smooth transition.”

To find out more information about either company, please visit www.valeant.com or www.salix.com.

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
The Power of Now: Unleashing Success through Direct Response Marketing
News
06/08/2024The Power of Now: Unleashing Success through Direct Response Marketing

When instant gratification became the order of the day, direct response marketing emerged as one of the most heavy-duty strategies businesses can adopt. It entails immediate action on the consumers’ part and thus has the possibility of enhanced engagemen

Read Full PostRead - Eye Icon
Early Easter Puts a Spring in Retailers’ Steps
Strategy
24/04/2015Early Easter Puts a Spring in Retailers’ Steps

David McCorquodale, UK head of retail comments on the benefits UK Retail saw during the early Easter.

Read Full PostRead - Eye Icon
Effective Strategies for Real Estate Investment
News
19/09/2022Effective Strategies for Real Estate Investment

What are your long-term financial goals? Do you want to have enough retirement savings to stop working sooner than most? Are you hoping to make more money now so that your family will be more comfortable in the years to come? Whatever your motivation is for br

Read Full PostRead - Eye Icon
A Distinguished Leader in Financial Restructuring
Finance
12/10/2023A Distinguished Leader in Financial Restructuring

As one of the ‘Big Four’, KPMG hardly needs an introduction. The company represents a leading player on the world stage, with thousands of employees working diligently to deliver truly distinguished results – together, for better. It’s a company that u

Read Full PostRead - Eye Icon
Orange & Vivendi Enter Negotiations for the Acquisition by Vivendi of a Stake in Dailymotion
Finance
08/04/2015Orange & Vivendi Enter Negotiations for the Acquisition by Vivendi of a Stake in Dailymotion

Orange and Vivendi will now enter into a period of exclusive negotiations in order to finalize the terms of this operation.

Read Full PostRead - Eye Icon
It’s All About Educating the Mind
Leadership
10/10/2016It’s All About Educating the Mind

Neurocoaching was founded and built by Patricia López, a mentor-coach, and telecommunications engineer for more than 20 years. The company is focused on developing engineers, whether it be getting the know themselves, skills, beliefs, or achieving their goals

Read Full PostRead - Eye Icon
Leading Logistics Provider
Innovation
09/03/2021Leading Logistics Provider

The importance of a smooth supply chain cannot be ignored in this day and age. A good supply chain doesn’t just revolve around moving products from one place to another but building lasting relationships. This approach is why the team at Digistics has been n

Read Full PostRead - Eye Icon
Seven Post-Pandemic Office Tech Trends to Look Out For
Innovation
08/04/2021Seven Post-Pandemic Office Tech Trends to Look Out For

As the pandemic has affected all aspects of our lives, the need for a new way of working is also affected. With that in mind, John Williams, Head of Marketing at Instant Offices reveals the top seven Proptech trends that aim to keep employee safe in a post-COV

Read Full PostRead - Eye Icon
AI and ESG: Where Do They Overlap?
Corporate Social Responsibility
06/11/2023AI and ESG: Where Do They Overlap?

AI and ESG are two boardroom topics that have more in common than you might think.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow